Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24524N0410
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On March 8, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $12,559.90 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque 90mg/30mg. This firm-fixed price delivery order, with an ultimate completion date of March 15, 2024, will be performed in Pittsburgh, Pennsylvania. The award was issued without a set-aside designation, reflecting Otsuka America Pharmaceutical Inc.'s status as an established large pharmaceutical manufacturer. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s parent General Services Administration Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, and supports procurement through the company's broader $83.3 million Blanket Purchase Agreement with the VA's National Acquisition Center. The BPA, which extends through March 26, 2026, enables VA facilities across multiple Integrated Service Networks to efficiently procure Jynarque and streamlines the delivery of critical pharmaceutical treatments to veterans nationwide. This award represents routine procurement activity under an established indefinite delivery vehicle, ensuring continued access to specialized pharmaceutical products across the Veterans Health Administration.
Quick answers
Who was awarded contract 36C24524N0410?
36C24524N0410 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 8, 2024.
How much is contract 36C24524N0410 worth?
The government has obligated $12,560 on 36C24524N0410.
Is contract 36C24524N0410 an order under another contract?
Yes. 36C24524N0410 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0410 competed?
The extent of competition for 36C24524N0410 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award